How long can leukaemia live after bone marrow transplantation

Update Date: 2021-04-12 Source: Network

summary

I believe everyone has heard of leukemia. Naturally, we know how harmful this disease is to the human body. If we want to treat this disease, we must do it through bone marrow transplantation. Let's talk about how long we can live after bone marrow transplantation for leukemia.

How long can leukaemia live after bone marrow transplantation

First, bone marrow transplantation, or hematopoietic stem cell transplantation, is a method of treating a series of diseases by intravenous infusion of hematopoietic stem and progenitor cells to reconstruct the normal hematopoiesis and immune system of patients. Hematopoietic stem cell transplantation has replaced the term "bone marrow transplantation" to a certain extent, because hematopoietic stem cells not only come from bone marrow, but also are mobilized into peripheral blood by hematopoietic factors.

Second, patients should do a series of blood and bone marrow tests before transplantation to determine the diagnosis, type and state of the disease, so as to determine the appropriate pretreatment scheme, monitoring of primary diseases after transplantation and appropriate intervention strategies. At the same time, the donors with identical HLA matching, healthy body and normal hematopoietic and immune system function should be selected.

Thirdly, the intensity of pretreatment is to prevent graft rejection to the maximum extent, and to achieve the tolerance of patients to its side effects, so there are a variety of pretreatment schemes to choose from. One of the key factors of non myeloablative hematopoietic stem cell transplantation is that the intensity of radiotherapy (chemoradiotherapy) is significantly lower than that of traditional regimen.

matters needing attention

For leukemia patients after bone marrow transplantation can live long, this problem has to be analyzed in detail, and can not be generalized, because the basic situation of each patient is not the same, which depends on many factors, such as the development speed of the disease and the quality of the patient.